Protection of focal ischemic infarction by rilmenidine in the animal: Evidence that interactions with central imidazoline receptors may be neuroprotective-Reference-Cited by-同舟云学术

Protection of focal ischemic infarction by rilmenidine in the animal: Evidence that interactions with central imidazoline receptors may be neuroprotective

Published:1994-12 Issue:13 Volume:74 Page:A25-A30
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Reis D.J.,Regunathan S.,Golanov E.V.,Feinstein D.L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference58 articles.

1. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem;Bricca;Eur J Pharmacol,1989

2. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla;Ernsberger;J Pharmacol Exp Ther,1990

3. Further characterization of the guinea pig cerebral cortex idazoxan receptor: solubilization, distinction from the imidazole site, and demonstration of cirazoline as an idazoxan receptor-selective drug;Wikberg;J Neurochem,1990

4. The imidazoline-preferring receptor;Lehmann;Life Sci,1989

5. Are there multiple imidazoline binding sites?;Michel;Trends Pharmacol Sci,1989

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imidazoline receptors as a new therapeutic target in Huntington’s disease: A preclinical overview;Ageing Research Reviews;2024-11

2. Dexmedetomidine Infusion Therapy;Infusion Therapy;2019

3. Dexmedetomidine protects against oxygen–glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells;Journal of Pharmacy and Pharmacology;2011-11-24

4. Review Article: Dexmedetomidine: Does it Have Potential in Palliative Medicine?;American Journal of Hospice and Palliative Medicine®;2010-12-03

5. Reversible inhibition of intracellular calcium influx through NMDA receptors by imidazoline I2 receptor antagonists;European Journal of Pharmacology;2010-03